Dergiler / Şişli Etfal Hastanesi Tıp Bülteni / 2019 / Cilt: 53 - Sayı: 1

Pleural Effusion in End Stage Renal Failure Patients

Sayfa
54–57
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

The causes of pleural effusion were infection (tuberculosis: n=20, 46%), pneumonia (n=3, 7%), empyema(n=1, 2%), malignancy (lung cancer: n=3, 7%; renal carcinoma: (1, 2%), collagen diseases (n=1, 2%), hepatic abscess (n=1, 2%),pulmonary thromboembolism (n=2, 4%), and idiopathic causes (n=11, 25%).Results: The causes of pleural effusion were infection (tuberculosis: n=20, 46%), pneumonia (n=3, 7%), empyema (n=1, 2%), malignancy (lung cancer: n=3, 7%; renal carcinoma: n=1, 2%), collagen disease (n=1, 2%), hepatic abscess (n=1, 2%), pulmonary thromboembolism (n=2, 4%), and idiopathic cases (n=11, 25%).Conclusion: Tuberculosis was the most common cause of pleural effusion that did not regress with dialysis treatment.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objectives: The aim of this study was to determine the causes of pleural effusion in patients who experienced end-stage renalfailure and did not demonstrate any regression of effusion with dialysis treatment.Methods: Patients with pleural effusion that did not regress though they attained dry weight with dialysis and those with 2 yearsof follow-up were included in the study.
📊
Temel Bulgular & Veri:The mean age of the patients was 48.16±14.5 years.
💡
Sonuç & Katkı:The causes of pleural effusion were infection (tuberculosis: n=20, 46%), pneumonia (n=3, 7%), empyema(n=1, 2%), malignancy (lung cancer: n=3, 7%; renal carcinoma: (1, 2%), collagen diseases (n=1, 2%), hepatic abscess (n=1, 2%),pulmonary thromboembolism (n=2, 4%), and idiopathic causes (n=11, 25%).Results: The causes of pleural effusion were infection (tuberculosis: n=20, 46%), pneumonia (n=3, 7%), empyema (n=1, 2%), malignancy (lung cancer: n=3, 7%; renal carcinoma: n=1, 2%), collagen disease (n=1, 2%), hepatic abscess (n=1, 2%), pulmonary thromboembolism (n=2, 4%), and idiopathic cases (n=11, 25%).Conclusion: Tuberculosis was the most common cause of pleural effusion that did not regress with dialysis treatment.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Objectives: The aim of this study was to determine the causes of pleural effusion in patients who experienced end-stage renalfailure and did not demonstrate any regression of effusion with dialysis treatment.Methods: Patients with pleural effusion that did not regress though they attained dry weight with dialysis and those with 2 yearsof follow-up were included in the study. The mean age of the patients was 48.16±14.5 years. Thirty-five patients were receivinghemodialysis treatment and 8 (18%) were continuous peritoneal dialysis patients. Ascites Ascites (n=6), pleural effusion (n=13),both ascites and pleural effusion (n=5), and pleural effusion that was bilateral (n=22, 51%), right-sided (n=13, 30%), and left-sided(n=8:18%) were detected. According to Light’s criteria, the pleural effusion was classified as exudate in 40 (93%) cases and transudate in 3 (7%). Microbiological examination did not identify any pathological agent in any case, and cytological examinations didnot reveal atypical cells. The causes of pleural effusion were infection (tuberculosis: n=20, 46%), pneumonia (n=3, 7%), empyema(n=1, 2%), malignancy (lung cancer: n=3, 7%; renal carcinoma: (1, 2%), collagen diseases (n=1, 2%), hepatic abscess (n=1, 2%),pulmonary thromboembolism (n=2, 4%), and idiopathic causes (n=11, 25%).Results: The causes of pleural effusion were infection (tuberculosis: n=20, 46%), pneumonia (n=3, 7%), empyema (n=1, 2%), malignancy (lung cancer: n=3, 7%; renal carcinoma: n=1, 2%), collagen disease (n=1, 2%), hepatic abscess (n=1, 2%), pulmonary thromboembolism (n=2, 4%), and idiopathic cases (n=11, 25%).Conclusion: Tuberculosis was the most common cause of pleural effusion that did not regress with dialysis treatment.

🔖

Bu Makaleye Atıf Yap

UZAN, G., İKİTİMUR, H. (2019). Pleural Effusion in End Stage Renal Failure Patients. Şişli Etfal Hastanesi Tıp Bülteni, Cilt: 53 - Sayı: 1, 54–57. https://ajindex.com/articles/363698

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (15)

  1. Cirit M, Akçiçek F, Terzioğlu E, Soydaş C, Ok E, Ozbaşli CF, et al. 'Paradoxical' rise in blood pressure during ultrafiltration in dialysis patients. Nephrol Dial Transplant 1995;10:1417–20
  2. Berger HW, Rammohan G, Neff MS, Buhain WJ. Uremic pleural effusion. A study in 14 patients on chronicdialysis. Ann Intern Med 1975;82:362–4
  3. Maher JF. Uremic pleuritis. Am J Kidney Dis 1987;10:19–22
  4. Nidus BD, Matalon R, Cantacuzino D, Eisinger RP. Uremic pleuritis- -a clinicopathological entity. N Engl J Med 1969;281:255–6
  5. Ray S, Mukherjee S, Ganguly J, Abhishek K, Mitras S, Kundu S. A cross-sectional prospective study of pleural effusion among cases of chronic kidney disease. Indian J Chest Dis Allied Sci 2013;55:209–13
  6. Kumar S, Agarwal R, Bal A, Sharma K, Singh N, Aggarwal AN, et al. Utility of adenosine deaminase (ADA), PCR & thoracoscopy in differentiating tuberculous & non-tuberculous pleural effusion complicating chronic kidney disease. Indian J Med Res 2015;141:308–14
  7. Kwan BC, Chow KM, Pang WF, Leung CB, Li PK, Szeto CC. Unexplained exudative pleural effusion in chronic peritoneal dialysis patients. Perit Dial Int 2010;30:534–40
  8. Light RW, Macgregor MI, Luchsinger PC, Ball WC Jr. Pleural effusions: the diagnostic separation of transudates and exudates. Ann Intern Med 1972;77:507–13
  9. Newberry WM, Sanford JP. Defective cellular immunity in renal failure: depression of reactivity of lymphocytes to phytohemagglutinin by renal failure serum. J Clin Invest 1971;50:1262–71
  10. Papadimitriou M, Memmos D, Metaxas P. Tuberculosis in patients on regular haemodialysis. Nephron 1979;24:53–7
  11. Gopi A, Madhavan SM, Sharma SK, Sahn SA. Diagnosis and treatment of tuberculous pleural effusion in 2006. Chest 2007;131:880–9
  12. Türk Toraks Derneği ve Türkiye Solunum Araştırmaları Derneği. Plevra Hastalıkları Tanı ve Tedavi Rehberi. Ankara, 2016
  13. ABRAMS LD. A pleural-biopsy punch. Lancet 1958;1:30–1
  14. Metintas M, Yildirim H, Kaya T, Ak G, Dundar E, Ozkan R, et al. CT Scan-Guided Abrams' Needle Pleural Biopsy versusUltrasoundAssisted Cutting Needle Pleural Biopsy for Diagnosis in Patients with Pleural Effusion: A Randomized, Controlled Trial. Respiration 2016;91:156–63
  15. Medford AR, Awan YM, Marchbank A, Rahamim J, UnsworthWhite J, Pearson PJ. Diagnostic and therapeutic performance of video-assisted thoracoscopic surgery (VATS) in investigation and management of pleural exudates. Ann R Coll Surg Engl 2008;90:597–600.